Regadenoson
Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist used as a coronary vasodilator in pharmacological stress testing. Its high selectivity and longer half-life compared to adenosine make it valuable for myocardial perfusion imaging in clinical and preclinical research, including studies of coronary flow reserve.
Product Specifications
CAS Number
313348-27-5
Product Name Alternative
Regadenoson, P1 receptor, myocardial perfusion imaging, inhibit, Inhibitor, Lexiscan, Adenosine Receptor, AdenosineReceptor, A2A, CBF, BBB, coronary, CVT3146, CVT-3146, CVT 3146
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
99.53% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.56 mM) ; DMSO:255 mg/mL (653.26 mM)
Smiles
CNC (=O) c1cnn (c1) -c1nc (N) c2ncn ([C@@H]3O[C@H] (CO) [C@@H] (O) [C@H]3O) c2n1
Molecular Formula
C15H18N8O5
Molecular Weight
390.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
